Hydromorphone Pregnancy and Breastfeeding Warnings

Hydromorphone is also known as: Dilaudid, Dilaudid-HP, Exalgo, Hydromorph Contin, Hydrostat IR, Palladone

Hydromorphone Pregnancy Warnings

Infants born to mothers physically dependent on hydromorphone will also be physically dependent and may exhibit respiratory difficulties and withdrawal symptoms.

Hydromorphone has been assigned to pregnancy category C by the FDA. Detailed information about the use of hydromorphone in pregnancy is not available. Animal studies have reported the occurrence of teratogenic effects at doses 600 times the human dose. Withdrawal symptoms have been reported in neonates whose mothers took other narcotic analgesics during pregnancy. In general, hydromorphone should only be given during pregnancy when benefit outweighs risk. However, the manufacturer reports that use of hydromorphone is contraindicated for obstetric analgesia.

Hydromorphone Breastfeeding Warnings

One study on eight lactating healthy women has reported that hydromorphone distributes rapidly from plasma into breast milk. However, the drug does not partition into fat. The suckling infant would receive approximately 0.67% of the maternal dose of hydromorphone (adjusted for body weight).

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)